Conor McNamara Analyst Performance

Equity Research Analyst at Royal Bank Of Canada

Conor McNamara is a stock analyst at Royal Bank Of Canada, covering 13 publicly traded companies across a range of sectors. Over the past year, Conor McNamara has issued 36 stock ratings, including buy and hold recommendations. While full access to Conor McNamara's proprietary MarketBeat Analyst Rating is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Conor McNamara's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rating: Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeat
Average Return: 00.00% 12-Month ROI
Success Rate: 00.00% Profitable Ratings
Total Ratings: 39 Last 2 Years
Buy Recommendations: 83.78% 31 Buy Ratings
Companies Covered: 13 Unique Companies

Ratings Distribution

Rating	Percentage	Count
Strong Buy	0.0%	0 ratings
Buy	83.8%	31 ratings
Hold	16.2%	6 ratings
Sell	0.0%	0 ratings

Out of 37 total stock ratings issued by Conor McNamara at Royal Bank Of Canada, the majority (83.8%) have been Buy recommendations, followed by 16.2% Hold.

Best & Worst Calls

Best Call
00.0%
ILMN
Dec 2023
Subscribe to MarketBeat All Access to get analyst recommendation ROI.
Worst Call
000.0%
ILMN
Apr 2023
Subscribe to MarketBeat All Access to get analyst recommendation ROI.

Exchange Coverage

Exchange	Percentage	Count
NASDAQ	69.2% of companies on NASDAQ	9 companies
NYSE	30.8% of companies on NYSE	4 companies

Conor McNamara, an analyst at Royal Bank Of Canada, currently covers 13 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.

Coverage Focus

Sector Icon	Sector	Percentage
	Medical 13 companies	100.0%

Conor McNamara of Royal Bank Of Canada specializes in stock coverage within the Medical sector.

Coverage Industries

Industry	Percentage
MED - BIOMED/GENE 4 companies	30.8%
MEDICAL SERVICES 3 companies	23.1%
MED PRODUCTS 3 companies	23.1%
MED INSTRUMENTS 2 companies	15.4%
MED - DRUGS 1 company	7.7%

Time Frame

Start Date

End Date

Rating

12-Month ROIAll ROI

Export to Excel

Company	Report Date	Action	Report Date Price	12-Month Price Target	Rating
TECH Bio-Techne	9/3/2025	Upgrade	$53.34		Moderate Buy
RGEN Repligen	9/2/2025	Reiterated Rating	$120.69	$205.00	Outperform
NTRA Natera	9/2/2025	Set Price Target	$169.34	$268.00	Outperform
ILMN Illumina	9/2/2025	Set Price Target	$97.82	$124.00
TMO Thermo Fisher Scientific	9/2/2025	Set Price Target	$484.86	$561.00	Outperform
TECH Bio-Techne	9/2/2025	Set Price Target	$53.42	$73.00	Outperform
MRVI Maravai LifeSciences	8/12/2025	Lower Price Target	$2.63	$5.00	Outperform
NTRA Natera	8/8/2025	Boost Price Target	$155.07	$255.00	Outperform
OABI OmniAb	8/7/2025	Lower Price Target	$1.80	$3.00	Outperform
EXAS Exact Sciences	8/7/2025	Lower Price Target	$41.90	$46.00	Sector Perform
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
TECH Bio-Techne	8/7/2025	Lower Price Target	$49.66	$61.00	Sector Perform
HOLX Hologic	8/6/2025	Upgrade	$67.82	$87.00	Outperform
AVTR Avantor	8/4/2025	Lower Price Target	$11.46	$17.00	Outperform
BIO Bio-Rad Laboratories	8/1/2025	Boost Price Target	$288.96	$409.00	Outperform
ILMN Illumina	8/1/2025	Boost Price Target	$96.89	$126.00	Outperform
RGEN Repligen	7/30/2025	Boost Price Target	$123.55	$204.00	Outperform
TECH Bio-Techne	5/8/2025	Lower Price Target	$50.25	$63.00	Sector Perform
BIO Bio-Rad Laboratories	5/2/2025	Lower Price Target	$238.79	$392.00	Outperform
HOLX Hologic	5/2/2025	Lower Price Target	$54.12	$70.00	Sector Perform
RGEN Repligen	4/30/2025	Lower Price Target	$135.08	$189.00	Outperform
AVTR Avantor	4/28/2025	Lower Price Target	$12.41	$20.00	Outperform
TMO Thermo Fisher Scientific	4/24/2025	Lower Price Target	$420.98	$637.00	Outperform
DHR Danaher	4/23/2025	Reiterated Rating	$198.87	$250.00	Outperform
ILMN Illumina	4/8/2025	Lower Price Target	$74.04	$112.00	Outperform
OABI OmniAb	3/27/2025	Lower Price Target	$2.46	$4.00	Outperform
NTRA Natera	3/13/2025	Initiated Coverage	$144.50	$251.00	Outperform
ILMN Illumina	3/12/2025	Lower Price Target	$82.89	$128.00	Outperform
RGEN Repligen	2/21/2025	Boost Price Target	$157.37	$205.00	Outperform
QDEL QuidelOrtho	2/13/2025	Lower Price Target	$41.91	$61.00	Outperform
AVTR Avantor	2/10/2025	Lower Price Target	$18.83	$31.00	Outperform
ILMN Illumina	2/7/2025	Lower Price Target	$111.40	$247.00	Outperform
TECH Bio-Techne	2/6/2025	Boost Price Target	$74.02	$80.00	Sector Perform
HOLX Hologic	2/6/2025	Lower Price Target	$66.51	$85.00	Sector Perform
TMO Thermo Fisher Scientific	1/31/2025	Set Price Target	$532.55	$693.00
DHR Danaher	1/30/2025	Reiterated Rating	$223.28	$277.00	Outperform
BIO Bio-Rad Laboratories	1/14/2025	Reiterated Rating	$346.61	$481.00	Outperform
ILMN Illumina	12/19/2023	Lower Price Target	$134.37	$258.00	Outperform

Stock Forecasts and Research Tools

Today's Ratings

Top-Rated Stocks

More Ratings Tools

Price Forecasts for Popular Stocks

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.